In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Innovation

Set Alert for Innovation

Biotech Foundations: Networks And Lab Space Are As Crucial As Funding

BioInnovation Institute chief business officer Bobby Soni shares how the life sciences incubator sources entrepreneurs and science globally, and the range of tools it provides to translate this into commercially viable companies. 

StartUps and SMEs Financing

Building Targeted Chemotherapies: ADCs, ProTides And ‘Click Chemistry’

If targeted therapies for cancer represent a more precise, laser-like attack on solid tumors and blood cancers, cytotoxic chemotherapies are more like a ham-fisted boxer punching every cell in sight. New methods for delivering chemotherapy directly into cancer cells may help to improve efficacy and reduce – or eliminate – damaging and sometimes deadly side effects.    

Innovation Cancer

Improving Outcomes Through Better Cancer Modeling

As leader of Stanford’s Cancer Computational and Systems Biology group, Christina Curtis, one of In Vivo’s 2021 Rising Leaders, is working to shed new light on the mysteries of metastatic cancer. Curtis’s use of computational models to analyze genetic mutations in breast cancer earned her an NIH Director’s Pioneer Award.

Rising Leaders Innovation

Kaiku Health To Build On 2020 Success With Rapid Expansion

With digital therapies and devices seeing widespread adoption in response to lockdown limitations during the COVID-19 pandemic, Kaiku Health is in a strong position to expand its patient monitoring software. CEO Lauri Sippola spoke with In Vivo about the platform and the company’s plans for 2021 and beyond.

Business Strategies Digital Health

The Big Health Care Conundrum: How To Sustainably Unlock The Value Of Diagnostics

With COVID-19 a residual but still very real issue globally, Novo Holdings asked the big diagnostics question at a recent high-level roundtable: How can stakeholders capitalize on this moment of acute public awareness of diagnostics to improve adoption of tests and screening in the long term? The CEOs of Roche Diagnostics, GE Healthcare, Labcorp and Synlab, among others, gave their thoughts on how the system must change.

Market Access In Vitro Diagnostics

Future Of Surgery: Virtual Reality, Robotics And Collaboration

Immersive technologies are becoming a reality in the OR. In Vivo explores the future of surgery, profiling innovators of augmented reality technologies and exploring the promise and challenges surrounding robotic surgery as companies try to take technologies to the next level. 

Robotics New Science

Growth Anticipated For RNA Therapies In New Indications

The approval of several novel RNA therapeutics in the last five years and the success of the COVID-19 mRNA vaccines has revived interest in the potential of RNA-based therapies. DTx Pharma hopes to use fatty acid conjugation to improve the delivery and duration of small interfering RNA therapeutics for rare diseases.

Innovation Companies

Transforming Cancer Drug Development Via Artificial Intelligence

Using a simulation-based drug discovery platform, Turbine is dramatically reshaping drug discovery and development, explains CEO and co-founder Szabolcs Nagy, a 2021 Rising Leader.

Innovation Rising Leaders

Psychedelic Supply Chain: New Business Models Anticipate Future Demand

Prescription psychedelic drugs in development, and supply for the growing recreational and medicinal use markets globally, are creating new business opportunities in mental health.

Cannabidiol CBD Innovation

New Science: Faster Development And Tech Convergence

Stuart Henderson, senior managing director and client lead for Accenture’s global life sciences practice, speaks to In Vivo about the emerging components of a winning biopharma development and portfolio strategy. CEOs are asking: “How do we change the cost of innovation?” says Henderson.

Innovation Digital Health

AI Accelerates In Drug Discovery

Artificial Intelligence has been hyped as a game changer in drug discovery for the last five years. How far has it come, and how far can it go? In Vivo talks to some of the key players that are creating and shaping the future of the industry.

Artificial Intelligence Clinical Trials

Precision And Prevention Key To Future Of Alzheimer’s Treatment

While a so-called disease modifying treatment has entered the market for the first time, in the form of Biogen’s Aduhelm, Alzheimer’s disease is unlikely to be cured by one drug alone. In Vivo explores the array of approaches to AD drug development, drawing on interviews with industry leaders and pipeline data.

Business Strategies Personalized Medicine
See All
UsernamePublicRestriction

Register